New antibiotics

Why new antibiotics never come to market :"For any discoveries that Murphy makes, the road ahead is paved with obstacles. Safety testing, animal testing, and then finally, the hope that a drug company and its investors can be persuaded to gamble hundreds of millions on the chemical passing the multiple stages of human clinical trials, before it can be turned into an over-the-counter product.

The odds seem slim, but with the annual global mortality rate from antibiotic resistance predicted to hit 10 million in the next 35 years, scientists remain hopeful that the politicians will come to better agreements on how to finance antibiotic development. The question is, will they get around to doing so before it’s too late?"

The Philanthrophy Hustle: "Increased charitable giving to the world’s wealthiest corporations is simply one novel aspect of a much bigger phenomenon: the growing power and clout of private philanthropic actors over global institutions such as the World Health Organization...." No money from the foundation seems to be goin to antibiotic research.